Rosmarinic acid attenuates TNF-α induced cardiomyocyte injury via regulating miR-344a-3p

To investigate whether rosmarinic acid protects cardiomyocytes from inflammatory damage through miRNAs, high-throughput sequencing and bioinformatics analysis were performed to identify TNF-α-induced inflammatory damage in cardiomyocytes and miRNAs differentially expressed in TNF-α-induced inflammatory injury in cardiomyocytes, and the bioinformatics analysis shown that the expression levels of 10 miRNAs were significantly up-regulated, and the expression levels of 6 miRNAs were significantly down-regulated. Among them, the expression level of miR-344a-3p was significantly up-regulated in the experimental group, while the expression level of miR-449c-5p was significantly down-regulated in experimental group of cells. The target genes of miR-344a-3p and miR-449c-5p were CCR1 and ATP2B4 respectively. The luciferase reporter system showed that luciferase activity in the WT-CCR1+miR-344a-3p mimic group was significantly decreased, and the expression of CCR1 was significantly decreased at mRNA and protein level after miR-344a-3p was transfected into H9C2 cells, indicating that TNF-α-induced inflammatory injury in cardiomyocytes, rosmarinic acid may up-regulate the expression of miR-344a-3p, thereby inhibiting the expression of CCR1 and ultimately protecting the cardiomyocytes from inflammatory damage. Thus, we thought that CCR1 might be a new therapeutic target for cardiomyocyte injury.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:70

Enthalten in:

Cellular and molecular biology (Noisy-le-Grand, France) - 70(2024), 1 vom: 31. Jan., Seite 207-212

Sprache:

Englisch

Beteiligte Personen:

Zhang, Jun [VerfasserIn]
Du, Yingqiang [VerfasserIn]
Li, Yafei [VerfasserIn]

Links:

Volltext

Themen:

EC 1.13.12.-
Journal Article
Luciferases
MQE6XG29YI
MicroRNAs
Rosmarinic Acid
Tumor Necrosis Factor-alpha

Anmerkungen:

Date Completed 20.02.2024

Date Revised 17.03.2024

published: Electronic

Citation Status MEDLINE

doi:

10.14715/cmb/2024.70.1.28

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368621553